The CDC director endorsed a pediatric Pfizer COVID-19 vaccine for children aged 5 to 11 years; proposed drug pricing reform will allow Medicare Part D to negotiate directly with pharmaceutical companies; some employers may not send death benefits to families of employees who die of COVID-19 without being vaccinated.
CDC Director Rochelle P. Walensky, MD, MPH, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation that children aged 5 to 11 years receive a Pfizer-BioNTech pediatric COVID-19 vaccine, the CDC said in a media statement Tuesday. This decision expanded vaccine access to approximately 28 million US children and allows providers to begin vaccinating them as soon as possible. Nationwide distribution of pediatric vaccines—which consist of two 10-mcg doses of the Pfizer vaccine—already started this week, with plans to scale up to full capacity starting the week of November 8. Pediatric Pfizer vaccines will be available at thousands of pediatric health care provider offices, pharmacies, federally qualified health centers, and other locations.
Democrats announced an agreement on drug pricing reform Tuesday, Politico reported. This new proposal allows Medicare Part D to negotiate directly with pharmaceutical companies for the first time, which the drug industry has fought against for nearly 2 decades. This proposal was made after a prior version was passed twice by the House. Although some view this version as “weaker,” progressives in both the House and the Senate are prepared to accept that it is the best agreement they may get in a narrowly divided Congress. The reform would also likely limit drug companies’ price increases to the 2021 inflation rate, which would only apply to individuals on private insurance plans and Medicare starting in 2022. Older adults on Medicare will have a limit of $2000 on what they pay out of pocket for medication.
More employers are beginning to implement a rule that if an employee dies of COVID-19 and was not vaccinated, their families may not get death benefits they otherwise would have received, Kaiser Health News reported. The New York Metropolitan Transportation Authority (MTA) no longer pays a $500,000 death benefit to families of subway, bus, and commuter rail workers who were unvaccinated and died of the virus. The MTA put the rule in place after struggling to improve vaccination rates among about 67,000 workers. In Massachusetts, the New Bedford City Council proposed legislation to extend accidental death benefits to city employees who died of COVID-19, but the mayor did not sign it partially because it did not prohibit payment if the employee was unvaccinated. Due to the wide availability of FDA-approved vaccines, more employers are expected to implement similar rules.
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More